Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT07506044

Dexmedetomidine as an Adjuvant During Dural Puncture Epidural

Conditions: Total Dose of Bupivacaine Administered During Labor

Sex: Female
Ages: 18 Years – 40 Years
Healthy volunteers: No
Phase: NA
Enrollment: 140
Sponsor: Menoufia University

Location: Faculty of Medicine Menoufia University Shebeen El Kom

Summary

The study aimed to determine the effects of using varied doses of DEX on the concentration of bupivacaine injected for epidural labor analgesia, and to assess the benefits of the dural puncture epidural.

Eligibility Criteria

Inclusion Criteria: * Women who attend the Emergency Department in labor, with cervical dilation of 3-5 cm, * normally presented singleton fetus, intact fetal membranes, and who are free of exclusion criteria Exclusion Criteria: Abnormal fetal presentation or lie, 'premature rupture of membranes, maternal fever, fetal distress, pregnancy-induced diseases * abnormal placental position, * ASA grade\>II * marked obesity, * allergy or contraindications to the used drugs, * spinal deformity or disorders 'cutaneous diseases or infection at the injection site

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07506044). StuddyBuddy aggregates publicly available trial information.